Rectal Cancer Global Clinical Trials Review, H2, 2013

GlobalData
November 30, 2013
131 Pages - SKU: GBDT5167364
Cancer Therapeutics
10/5/2015 | published by: Kalorama Information
Kalorama's Cancer Therapeutics provides market estimates and forecasts for the market for cancer treatments.  This title will focus on novel treatments.  |  read more...
USD 3,995
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease
2/24/2015 | published by: MP Advisors
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease While targeting unmet needs in the treatment of hematological malignancies/ cancer through  |  read more...
USD 3,000
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019
2/18/2015 | published by: MarketsandMarkets
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019 Pyrogen testing  |  read more...
USD 4,650
The Market for Personalized Gene Therapy Treatments for Cancer
12/23/2014 | published by: Kalorama Information
The Market for Personalized Gene Therapy Treatments for Cancer This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach  |  read more...
USD 3,995
2015 Germany Cancer Diagnostic Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test
1/23/2015 | published by: VPGMarketResearch.com
2015 Germany Cancer Diagnostic Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test This report provides an overview of the German cancer diagnostics market, including market shares of leading suppliers by test, as  |  read more...
USD 750
2015 Japan Cancer Diagnostic Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test
1/23/2015 | published by: VPGMarketResearch.com
2015 Japan Cancer Diagnostic Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test This report provides an overview of the Japanese cancer diagnostics market, including market shares of leading suppliers by test, as  |  read more...
USD 750
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market
1/28/2015 | published by: Frost & Sullivan
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market The estimated market size for lung cancer therapeutics in 2014 was $?? billion. There is increasing competition in this market, especially amongst  |  read more...
USD 5,000
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019
1/26/2015 | published by: MarketsandMarkets
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019 The vaccines market is  |  read more...
USD 4,650
Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Multiple Myeloma (Kahler's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Multiple Myeloma (Kahler's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Multiple Myeloma (Kahler's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!